0000899243-19-024838.txt : 20191002 0000899243-19-024838.hdr.sgml : 20191002 20191002214529 ACCESSION NUMBER: 0000899243-19-024838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191002 FILED AS OF DATE: 20191002 DATE AS OF CHANGE: 20191002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lucchino David L. CENTRAL INDEX KEY: 0001785288 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 191134217 MAIL ADDRESS: STREET 1: C/O FREQUENCY THERAPEUTICS, INC. STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19 PRESIDENTIAL WAY, SUITE 203 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 19 PRESIDENTIAL WAY, SUITE 203 CITY: WOBURN STATE: MA ZIP: 01801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-10-02 0 0001703647 Frequency Therapeutics, Inc. FREQ 0001785288 Lucchino David L. C/O FREQUENCY THERAPEUTICS, INC., 19 PRESIDENTIAL WAY, 2ND FLOOR WOBURN MA 01801 1 1 0 0 President and CEO Stock Option 3.37 2019-04-17 4 A 0 96361 0.00 A 2029-04-16 Common Stock 96361 96361 D Stock Option 3.37 2019-04-17 4 A 0 444371 0.00 A 2029-04-16 Common Stock 444371 444371 D Stock Option 14.00 2019-10-02 4 A 0 714413 0.00 A 2029-10-01 Common Stock 714413 714413 D This transaction is being reported pursuant to Rule 16a-2(a), and the securities covered by such transaction were previously included on the Reporting Person's Form 3. The option is fully vested. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2019, and will be fully vested and exercisable on January 1, 2023. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on November 2, 2019, and will be fully vested and exercisable on October 2, 2023. By: /s/ Michael D. Bookman, Attorney-in-Fact for David L. Lucchino 2019-10-02